http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100115410-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_046b94174ff188b5b5d0c4605583ee11 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-30 |
| filingDate | 2009-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99445c9edbdc58ec79df99924a0210aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15accf3de3a76b2b4fdda596b10675c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c37771ca15c361e48e198b79ccd0525f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_242696091dd7a2af135ddfc9aeaea07e |
| publicationDate | 2010-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100115410-A |
| titleOfInvention | Novel naphthalene derivative compound and pharmaceutical composition for enhancing immune response comprising the same as an active ingredient |
| abstract | The present invention relates to a novel naphthalene derivative compound and a pharmaceutical composition for enhancing immune response comprising the same as an active ingredient. The naphthalene derivative compound, which is an active ingredient of the pharmaceutical composition of the present invention, enhances the processing of antigens in Antigen Presenting Cells (APCs) through the Major Histocompatibility Complex (MHC). Surprisingly improves antigen presentation levels. Accordingly, the pharmaceutical composition of the present invention significantly promotes the efficiency of the antigen-presenting cells in treating T-cells by treating external antigens that are harmful to the human body, thereby increasing the immune response mediated by T-cells to a very high level. It is expected to have an effect that can be augmented. |
| priorityDate | 2009-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 175.